
National Jun 28, 2022
COVID-19 tracker: Tokyo's new infections mark week-on-week rise for 11th day
The capital confirmed 2,514 new infections Tuesday, rising 551 from a week earlier.
COVID-19 tracker: Tokyo's new infections mark week-on-week rise for 11th day
The capital confirmed 2,514 new infections Tuesday, rising 551 from a week earlier.
COVID-19 tracker: New cases in Japan rise week-on-week for seventh day
The seven-day average of new cases in the capital came to 2,081, compared with 1,619.6 a week earlier.
Despite official nudges, Japanese still not unmasking outside
Amid a brutal heatwave, the government is urging people to shed their masks when outside, but peer pressure still prevails for now.
The seven-day average of new daily cases in the capital rose 25.9% to 2,018.
More than 3,200 confirmed cases and one death have now been reported to the WHO from more than 50 countries this year.
The capital also reported two new deaths linked to COVID-19, while the seven-day average of new infections rose 23.3% to 1,963.4.
Abortion pills over the counter? Experts see big hurdles in widening U.S. access.
A pill used to terminate early pregnancies is unlikely to become available in the U.S. without a prescription for years, if ever, experts say.
Japan begins return to business-as-usual at big events — but slowly
Recent trials of allowing cheering at soccer games are indicative of the approach toward large events in the coming months: a slow, highly cautious return to some aspects of normalcy.
The seven-day average of new infections in the capital rose 20.7% to reach 1,895.
An education ministry survey showed that children's uncorrected vision got progressively worse as they moved through grades, with the phenomenon especially prominent among girls.
COVID-19 tracker: Tokyo reports 2,413 new cases, up 600 from week before
The seven-day average of new cases came to 1,811.4, compared with 1,570.6 a week earlier.
Japanese panel postpones verdict on Shionogi’s COVID pill until July
The panel “could not reach a conclusion,” as its members were divided over several points including the efficacy of the drug, according to a health ministry official.